Alcohol abuse in deceased liver donors: Impact on post-transplant outcomes

Liver International

Volumn 35, Issue 1, 2015, Pages 171-175

  Mangus, Richard S ^a   Kubal, Chandrashekhar A ^a   Fridell, Jonathan A ^a   Pena, Jose M ^a   Frost, Evan M ^a   Joseph Tector, A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol abuse; Extended criteria donors; Orthotopic liver transplant; Outcomes

Indexed keywords

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALLOGRAFT; ARTICLE; DRINKING BEHAVIOR; FATTY LIVER; FEMALE; GRAFT FAILURE; GRAFT NECROSIS; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER GRAFT; LIVER PERFUSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGAN DONOR; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; REPERFUSION; RISK ASSESSMENT; SURVIVAL TIME; ALCOHOLISM; COMPLICATION; DONOR; DONOR SELECTION; PHYSIOLOGY; PRIMARY GRAFT DYSFUNCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ALCOHOLISM; DONOR SELECTION; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; PRIMARY GRAFT DYSFUNCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 84921054638     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12484     Document Type: Article

References (11)

1. Tector AJ, Mangus RS, Chestovich P, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439-50.
2. Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 2008; 14: 1694-707.
3. Renz JF, Kin C, Kinkhabwala M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation.Ann Surg 2005; 242:556-63.discussion 563-5.
4. Mangus RS, Fridell JA, Vianna RM, et al. No difference in clinical transplant outcomes for local and imported liver allografts. Liver Transpl 2009; 15: 640-7.
5. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat 10 2012; 252:1-207.
6. Mangus RS, Fridell JA, Vianna RM, et al. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up. Liver Transpl 2012; 18: 786-95.
7. Mangus RS, Tector AJ, Agarwal A, et al. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl 2006; 12: 226-30.
8. Mangus RS, Fridell JA, Vianna RM, et al. Use of the piggyback hepatectomy technique in liver transplant recipients with hepatocellular carcinoma. Transplantation 2008; 85: 1496-9.
9. Mangus R, Borup TC, Popa S, et al. Utility of pre-procurement bedside liver biopsy in the deceased extended criteria liver donor. Clin Transplant 2013; In press.
10. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003; 37: 493-503.
11. Mathurin P, Deltenre P. Effect of binge drinking on the liver: an alarming public health issue? Gut 2009; 58: 613-7.